#gep_nets - Twitter Hashtag

about 15 hours ago

Bristol Myers Squibb Announces Positive Topline Results from Interim Phase 3 ACTION-1 Analysis of RYZ101 in Patients with GEP-NETs - For More Information Visit https://t.co/jJppJMGpwq @bmsnews #Rare_Diseases #GEP_NETs #Orphan_Drugs #Cancer_drugs #Cancer_research

CheckOrphan's tweet photo. Bristol Myers Squibb Announces Positive Topline Results from Interim Phase 3 ACTION-1 Analysis of RYZ101 in Patients with GEP-NETs - For More Information Visit https://t.co/jJppJMGpwq @bmsnews #Rare_Diseases #GEP_NETs #Orphan_Drugs #Cancer_drugs #Cancer_research https://t.co/lFbbWFeSAl

0

2

0

75

Med Learning Group @MLG_CME

3 days ago

📣 Our Complimentary CME/CNE webinar series on GEP-NETs begins October 14! 🎓 1.0 AMA PRA Category 1 Credit™ and 1.0 ANCC contact hour Find a session that fits your schedule @ https://t.co/X5lmYJt0EP #GEP_NETs #NeuroendocrineTumors #Oncology #CME #CNE #MedLearningGroup

MLG_CME's tweet photo. 📣 Our Complimentary CME/CNE webinar series on GEP-NETs begins October 14!

🎓 1.0 AMA PRA Category 1 Credit™ and 1.0 ANCC contact hour

Find a session that fits your schedule @ https://t.co/X5lmYJt0EP

#GEP_NETs #NeuroendocrineTumors #Oncology #CME #CNE #MedLearningGroup https://t.co/uuZDY0CtiB

0

37

SEMNIM @SEMNIMoficial

10 months ago

“Compete da argumentos para que [¹⁷⁷Lu]Lu-Edotreótido se considere un tratamiento central y temprano en GEP-NETs”. La Dra. García Burillo explica el impacto clínico del PRRT. 👉 Entrevista: https://t.co/fLbwjKxT6q #MedicinaNuclear #PRRT #GEP_NETs #Teragnosis #SEMNIM

0

10

9

2

524

Nieves Martinez Lago MD PhD

@DraMartinezLago

12 months ago

#ESMO25 | #RadioligandTherapy Phase II ALPHAMEDIX-02 studied 212Pb-DOTAMTATE in advanced GEP-NETs post-PRRT. 🧠 ORR 34.6%, DCR 96.2% 📈 18-mo PFS 82.6%, OS 85.1% 💊 Safe, no MDS/AML Promising post-PRRT option for #GEP_NETs. @myESMO @OncoAlert

DraMartinezLago's tweet photo. #ESMO25 | #RadioligandTherapy

Phase II ALPHAMEDIX-02 studied 212Pb-DOTAMTATE in advanced GEP-NETs post-PRRT.

🧠 ORR 34.6%, DCR 96.2%
📈 18-mo PFS 82.6%, OS 85.1%
💊 Safe, no MDS/AML

Promising post-PRRT option for #GEP_NETs.

@myESMO @OncoAlert https://t.co/8Jfc81rapQ

2

25

12

6

2K

Nieves Martinez Lago MD PhD

@DraMartinezLago

12 months ago

#ESMO25 | #RadioligandTherapy Phase II ALPHAMEDIX-02 studied 212Pb-DOTAMTATE in advanced GEP-NETs post-PRRT. 🧠 ORR 34.6%, DCR 96.2% 📈 18-mo PFS 82.6%, OS 85.1% 💊 Safe, no MDS/AML Promising post-PRRT option for #GEP_NETs.

0

8

3

1

686

Top Tweets for #gep_nets

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users